Risk of myocarditis after three doses of COVID-19 mRNA vaccines in the United States, 2020-2022: A self-controlled case series study.

Daoyuan LaiDickson LimJunfeng LuHan WangTao HuangYan Dora Zhang

Published in: Journal of evidence-based medicine (2024)

These findings raise safety concerns regarding COVID-19 mRNA vaccines, provide insights into the quantification of myocarditis risk at different postvaccination periods, and offer a novel approach to interpreting passive surveillance system data.

Keyphrases

coronavirus disease
sars cov
public health
binding protein
electronic health record
big data
machine learning
data analysis
breast cancer risk